Walmsley will step down from the board of directors of GSK at the end of the year, and will step down as CEO on 30th ...
Background: Determining optimal timing for intensifying the frequency of physician encounters for type 2 diabetes mellitus (T2DM) requires trade-offs between timely care and clinician burden. We aimed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback